-+ 0.00%
-+ 0.00%
-+ 0.00%

D. Boral Capital Maintains Buy on Hoth Therapeutics, Maintains $5 Price Target

Benzinga·04/03/2025 11:07:42
Listen to the news
D. Boral Capital analyst Jason Kolbert maintains Hoth Therapeutics (NASDAQ:HOTH) with a Buy and maintains $5 price target.